Stable Colloidal Drug Aggregates Catch and Release Active Enzymes

ACS Chemical Biology

Volumn 11, Issue 4, 2016, Pages 992-1000

  McLaughlin, Christopher K ^a,b   Duan, Da ^c   Ganesh, Ahil N ^a,b   Torosyan, Hayarpi ^c   Shoichet, Brian K ^c   Shoichet, Molly S ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AZO DYE; BETA LACTAMASE; CHLOROTRIANISENE; CONGO RED; EVANS BLUE; FULVESTRANT; LAPATINIB; MALATE DEHYDROGENASE; NILOTINIB; PHENOLPHTHALEIN; SORAFENIB; TETRAIODOPHENOLPHTHALEIN; TRYPSIN; UNCLASSIFIED DRUG; VEMURAFENIB; COLLOID;

ARTICLE; BREAST CANCER CELL LINE; CELL VIABILITY; COLLOID; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG FORMULATION; DRUG STABILITY; ENZYME ACTIVITY; ENZYME RELEASE; IONIC STRENGTH; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN BINDING; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; ADMINISTRATION AND DOSAGE; METABOLISM;

BETA-LACTAMASES; COLLOIDS; PARTICLE SIZE;

EID: 84966431089     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/acschembio.5b00806     Document Type: Article

References (30)

1. Shoichet, B. K. (2006) Screening in a spirit haunted world Drug Discovery Today 11, 607-615 10.1016/j.drudis.2006.05.014
2. Brick, M. C., Palmer, H. J., and Whitesides, T. H. (2003) Formation of colloidal dispersions of organic materials in aqueous media by solvent shifting Langmuir 19, 6367-6380 10.1021/la034173o
3. McGovern, S. L., Caselli, E., Grigorieff, N., and Shoichet, B. K. (2002) A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening J. Med. Chem. 45, 1712-1722 10.1021/jm010533y
4. McGovern, S. L., Helfand, B. T., Feng, B., and Shoichet, B. K. (2003) A specific mechanism of nonspecific inhibition J. Med. Chem. 46, 4265-4272 10.1021/jm030266r
5. Thorne, N., Auld, D. S., and Inglese, J. (2010) Apparent activity in high-throughput screening: origins of compound-dependent assay interference Curr. Opin. Chem. Biol. 14, 315-324 10.1016/j.cbpa.2010.03.020
6. Coan, K. E., Ottl, J., and Klumpp, M. (2011) Non-stoichiometric inhibition in biochemical high-throughput screening Expert Opin. Drug Discovery 6, 405-417 10.1517/17460441.2011.561309
7. Dahlin, J. L. and Walters, M. A. (2014) The essential roles of chemistry in high-throughput screening triage Future Med. Chem. 6, 1265-1290 10.4155/fmc.14.60
8. Feng, B. Y., Simeonov, A., Jadhav, A., Babaoglu, K., Inglese, J., Shoichet, B. K., and Austin, C. P. (2007) A high-throughput screen for aggregation-based inhibition in a large compound library J. Med. Chem. 50, 2385-2390 10.1021/jm061317y
9. Doak, A. K., Wille, H., Prusiner, S. B., and Shoichet, B. K. (2010) Colloid formation by drugs in simulated intestinal fluid J. Med. Chem. 53, 4259-4265 10.1021/jm100254w
10. Owen, S. C., Doak, A. K., Wassam, P., Shoichet, M. S., and Shoichet, B. K. (2012) Colloidal aggregation affects the efficacy of anticancer drugs in cell culture ACS Chem. Biol. 7, 1429-1435 10.1021/cb300189b
11. Seidler, J., McGovern, S. L., Doman, T. N., and Shoichet, B. K. (2003) Identification and prediction of promiscuous aggregating inhibitors among known drugs J. Med. Chem. 46, 4477-4486 10.1021/jm030191r
12. Irwin, J. J., Duan, D., Torosyan, H., Doak, A. K., Ziebart, K. T., Sterling, T., Tumanian, G., and Shoichet, B. K. (2015) An Aggregation Advisor for Ligand Discovery J. Med. Chem. 58, 7076 10.1021/acs.jmedchem.5b01105
13. Ilevbare, G. A. and Taylor, L. S. (2013) Liquid-Liquid Phase Separation in Highly Supersaturated Aqueous Solutions of Poorly Water-Soluble Drugs: Implications for Solubility Enhancing Formulations Cryst. Growth Des. 13, 1497-1509 10.1021/cg301679h
14. Almeida e Sousa, L., Reutzel-Edens, S. M., Stephenson, G. A., and Taylor, L. S. (2015) Assessment of the amorphous "solubility" of a group of diverse drugs using new experimental and theoretical approaches Mol. Pharmaceutics 12, 484-495 10.1021/mp500571m
15. Sassano, M. F., Doak, A. K., Roth, B. L., and Shoichet, B. K. (2013) Colloidal aggregation causes inhibition of G protein-coupled receptors J. Med. Chem. 56, 2406-2414 10.1021/jm301749y
16. Ilevbare, G. A., Liu, H., Edgar, K. J., and Taylor, L. S. (2013) Impact of polymers on crystal growth rate of structurally diverse compounds from aqueous solution Mol. Pharmaceutics 10, 2381-2393 10.1021/mp400029v
17. Ilevbare, G. A., Liu, H. Y., Edgar, K. J., and Taylor, L. S. (2013) Maintaining Supersaturation in Aqueous Drug Solutions: Impact of Different Polymers on Induction Times Cryst. Growth Des. 13, 740-751 10.1021/cg301447d
18. Jackson, M. J., Toth, S. J., Kestur, U. S., Huang, J., Qian, F., Hussain, M. A., Simpson, G. J., and Taylor, L. S. (2014) Impact of polymers on the precipitation behavior of highly supersaturated aqueous danazol solutions Mol. Pharmaceutics 11, 3027-3038 10.1021/mp500201s
19. Grohganz, H., Priemel, P. A., Lobmann, K., Nielsen, L. H., Laitinen, R., Mullertz, A., Van den Mooter, G., and Rades, T. (2014) Refining stability and dissolution rate of amorphous drug formulations Expert Opin. Drug Delivery 11, 977-989 10.1517/17425247.2014.911728
20. D'Addio, S. M. and Prud'homme, R. K. (2011) Controlling drug nanoparticle formation by rapid precipitation Adv. Drug Delivery Rev. 63, 417-426 10.1016/j.addr.2011.04.005
21. Lepeltier, E., Bourgaux, C., and Couvreur, P. (2014) Nanoprecipitation and the "Ouzo effect": Application to drug delivery devices Adv. Drug Delivery Rev. 71, 86-97 10.1016/j.addr.2013.12.009
22. Fuhrmann, K., Gauthier, M. A., and Leroux, J. C. (2014) Targeting of injectable drug nanocrystals Mol. Pharmaceutics 11, 1762-1771 10.1021/mp5001247
23. Feng, B. Y., Toyama, B. H., Wille, H., Colby, D. W., Collins, S. R., May, B. C., Prusiner, S. B., Weissman, J., and Shoichet, B. K. (2008) Small-molecule aggregates inhibit amyloid polymerization Nat. Chem. Biol. 4, 197-199 10.1038/nchembio.65
24. Skowronek, M., Roterman, I., Konieczny, L., Stopa, B., Rybarska, J., and Piekarska, B. (2000) Why Do Congo Red, Evans Blue, and Trypan Blue Differ in Their Complexation Properties? J. Comput. Chem. 21, 656-667 10.1002/(SICI)1096-987X(200006)21:8<656::AID-JCC5>3.0.CO;2-J
25. Feng, B. Y. and Shoichet, B. K. (2006) Synergy and antagonism of promiscuous inhibition in multiple-compound mixtures J. Med. Chem. 49, 2151-2154 10.1021/jm060029z
26. Feng, B. Y., Shelat, A., Doman, T. N., Guy, R. K., and Shoichet, B. K. (2005) High-throughput assays for promiscuous inhibitors Nat. Chem. Biol. 1, 146-148 10.1038/nchembio718
27. Feng, B. Y. and Shoichet, B. K. (2006) A detergent-based assay for the detection of promiscuous inhibitors Nat. Protoc. 1, 550-553 10.1038/nprot.2006.77
28. Coan, K. E., Maltby, D. A., Burlingame, A. L., and Shoichet, B. K. (2009) Promiscuous aggregate-based inhibitors promote enzyme unfolding J. Med. Chem. 52, 2067-2075 10.1021/jm801605r
29. Owen, S. C., Doak, A. K., Ganesh, A. N., Nedyalkova, L., McLaughlin, C. K., Shoichet, B. K., and Shoichet, M. S. (2014) Colloidal drug formulations can explain "bell-shaped" concentration-response curves ACS Chem. Biol. 9, 777-784 10.1021/cb4007584
30. Weston, G. S., Blazquez, J., Baquero, F., and Shoichet, B. K. (1998) Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase J. Med. Chem. 41, 4577-4586 10.1021/jm980343w